Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason C Gallagher

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2020
Bacteria Keep Reminding Us: There Are No Silver BulletsJason C Gallagher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2023
Taking on the Fundamental Questions in Infectious Diseases Two-at-a-TimeJason C Gallagher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2025
We cannot overcome the mediocrity of colistinJason C Gallagher
Expert Review of Anti-Infective Therapy|June 16, 2005
Amphotericin B deoxycholate: time to retire our old standard?Jason C Gallagher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 2, 2019
Omadacycline: A Modernized TetracyclineJason C Gallagher
The Annals of Pharmacotherapy|October 13, 2011
Moxifloxacin as an alternative or additive therapy for treatment of pulmonary tuberculosisMohamed Fouad, Jason C Gallagher
JAMA|January 12, 2023
Lack of Benefit of Fluvoxamine for COVID-19Adarsh Bhimraj, Jason C Gallagher
The Annals of Pharmacotherapy|February 25, 2010
Prophylactic antifungal agents used after lung transplantationElizabeth Marino, Jason C Gallagher
The Annals of Pharmacotherapy|February 6, 2009
Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances?Jane Frumin, Jason C Gallagher
The Annals of Pharmacotherapy|October 30, 2014
Vancomycin-resistant enterococcal bacteremia pharmacotherapyRuchi Patel, Jason C Gallagher
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2020
Bacteria Keep Reminding Us: There Are No Silver BulletsJason C Gallagher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2023
Taking on the Fundamental Questions in Infectious Diseases Two-at-a-TimeJason C Gallagher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2025
We cannot overcome the mediocrity of colistinJason C Gallagher
Expert Review of Anti-Infective Therapy|June 16, 2005
Amphotericin B deoxycholate: time to retire our old standard?Jason C Gallagher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 2, 2019
Omadacycline: A Modernized TetracyclineJason C Gallagher
The Annals of Pharmacotherapy|October 13, 2011
Moxifloxacin as an alternative or additive therapy for treatment of pulmonary tuberculosisMohamed Fouad, Jason C Gallagher
JAMA|January 12, 2023
Lack of Benefit of Fluvoxamine for COVID-19Adarsh Bhimraj, Jason C Gallagher
The Annals of Pharmacotherapy|February 25, 2010
Prophylactic antifungal agents used after lung transplantationElizabeth Marino, Jason C Gallagher
The Annals of Pharmacotherapy|February 6, 2009
Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances?Jane Frumin, Jason C Gallagher
The Annals of Pharmacotherapy|October 30, 2014
Vancomycin-resistant enterococcal bacteremia pharmacotherapyRuchi Patel, Jason C Gallagher
Pageof 7